ArticleCurrent oncology (Toronto, Ont.)2022

Study of PD-1 Inhibitors in Combination with Chemoradiotherapy/Chemotherapy in Patients with Esophageal Squamous Carcinoma.

Tianhui Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.